4:22 PM
 | 
Oct 11, 2017
 |  BC Extra  |  Company News

Management tracks: Aerpio, Scancell, TCR2

Ophthalmic company Aerpio Pharmaceuticals Inc. (OTCQB:ARPO) named Stephen Hoffman CEO, effective Dec. 1, 2017. He succeeds Aerpio founder Joseph Gardner, who will remain its president. Hoffman was a senior advisor at PDL BioPharma Inc. (NASDAQ:PDLI), and was a managing director at Skyline Ventures.

Cancer immunotherapy company Scancell Holdings plc (LSE:SCLP; FSE:SCP) named Cliff Holloway CEO, effective Jan. 10, 2018. He was chief business officer and COO at Benitec Biopharma Ltd. (ASX:BLT; NASDAQ:BNTC).

Diagnostics company Meridian Bioscience Inc. (NASDAQ:VIVO) named Jack Kenny CEO. He succeeds John Kraeutler, who will...

Read the full 447 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >